BLI · Categories · M&A
BLI - Mergers and acquisitions
Berkeley Lights Inc. (BLI) mergers and acquisitions - real-time wire coverage filtered to M&A only.
Recent M&A for BLI
- Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody DiscoveryEMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (NASDAQ:BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and develops antibodies for immunotechnology therapeutics and research, today announced the acquisition of the Berkeley Lights Beacon® system via a TechAccess subscription to help further its mission of helping its customers in the generation and validation of novel therapeutic antibodies against cancer and inflammatory diseases. This marks the first Beacon platform to be used in France, which enables MImAbs to further their commitment to providing their research institutions, public technology tran
- Berkeley Lights Announces GSK Acquires Third Beacon® Optofluidic System to Expand Antibody Therapeutics DevelopmentEMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (NASDAQ:BLI), a leader in digital cell biology, today announced that GlaxoSmithKline (NYSE: GSK) has purchased an additional Beacon™ Optofluidic system to expand its antibody therapeutics capacity. The new Beacon system will leverage Berkeley Lights' Opto™ Plasma B Discovery workflow to perform functional analysis, further accelerating the lead selection process. "We are pleased that GSK has again selected the Beacon Optofluidic system as part of their ongoing activities to accelerate discovery, development, and delivery of therapeutics," said Eric Hobbs, Ph.D., chief executive officer of Berkeley Lights. "BLI's